Patisiran in Patients with Transthyretin Cardiac Amyloidosis No … ← JAK Inhibition in STAT1 Gain-of-Function-Mediated Treatment-Resistant Autoimmune Hepatitis Patisiran in Patients with Transthyretin Cardiac Amyloidosis. Reply →